<!DOCTYPE ui:UiBinder SYSTEM "http://dl.google.com/gwt/DTD/xhtml.ent">
<ui:UiBinder xmlns:ui="urn:ui:com.google.gwt.uibinder"
	xmlns:g="urn:import:com.google.gwt.user.client.ui"
	xmlns:w="urn:import:com.lmc.der.sixComposers.client.widgets"
	xmlns:tbl="urn:import:com.lmc.der.sixComposers.client.widgets.tables"
	xmlns:tbl_ama="urn:import:com.lmc.der.sixComposers.client.widgets.tables.ama"
	>
	<ui:style>
		
	</ui:style>
	<g:HTMLPanel width="170ex">
		<div style="font-weight:bold">
			Table 8: Summary of Test Concentrations in the Amphibian Metamorphosis Assay with [test chemical].
		</div>
		<table>
		<col style="width:80%"/><col style="width:20%"/>
		<tr>
		<td>
			<tbl_ama:AMA2Table8/>
		</td>
		<td style="font-style:italic">
			Guideline Recommendations:
			EPA and OECD recommend that test item concentrations be
			maintained at a coefficient of variation (CV) &le;20%. 
		</td>
		</tr></table>
		<table>
		<tr>
			<td>
				<g:Button btnName='TBL8_ADD'>
					Add Test concentration					
				</g:Button>
			</td>
			<td>
				<g:Button btnName='TBL8_REM'>
					Remove Test concentration
				</g:Button>
			</td>
			<td>
				Abbreviations: 						
				<sup>CV</sup> Coefficient of variation.
			</td>						 
		</tr>
		</table>
		<table>
			<tr>
				<td>
					E. Observations
				</td>
			</tr>
			<tr>
				<td>
					Biological Endpoints:
				</td>
				<td>
					<w:DERRichTextAreaPUT name="AMA||MaterialsAndMethods>>Observations>>BiologicalEndpoints>>Html"  addStyleNames='bigRTA' ui:field='rtaBE'>
						<p style="color:firebrick">
								[List the parameters measured, including the specific clinical signs/sublethal effects that were considered.  Include the measurement interval for each observation (e.g., daily, day 7 and 21, day 21, other).]
						</p>
					</w:DERRichTextAreaPUT>
				</td>
			</tr>
			<tr>
				<td>
					Were raw (individual) data provided?  
				</td>
				<td>
					<w:DERListBoxYesNo name="AMA||MaterialsAndMethods>>Observations>>IndividualDataProvided" ui:field='lbRD'/>
				</td>
			</tr>
			<tr style="font-style:italic">
				<td colspan="2">
				EPA recommends that observations of mortality and clinical signs occur daily, at a minimum; other observations are recommended as follows: NF developmental stage (days 7 and 21); any asynchronous development, indicated by tadpoles that cannot be assigned an NF stage (days 7 and 21); hind limb length (days 7 and 21); snout-vent length (days 7 and 21);  body weight (test initiation, for optional size-based larval selection); and thyroid gland gross pathology and histopathology (day 21).  Note the histopathology section of the test guideline also includes thyroid gross pathology observations.
				</td>
			</tr>
		</table>
	</g:HTMLPanel>
</ui:UiBinder> 